The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N
(Journal of Medicinal Chemistry)
Thursday August 16th 2012
Author(s): Martin H. Bolli, Christoph Boss, Christoph Binkert, Stephan Buchmann, Daniel Bur, Patrick Hess, Marc Iglarz, Solange Meyer, Josiane Rein, Markus Rey, Alexander Treiber, Martine Clozel, Walter Fischli, Thomas Weller,
DOI:10.1021/jm3009103
GO TO: [Article]
Other Relevant Articles (Match %)
- 62.4%
meso-Pyrimidinyl-Substituted A2B- and A3-Corroles
[Article]
- 59.7%
Synthetic, Structural, and Photophysical Exploration of meso-Pyrimidinyl-Substituted AB2-Corroles
[Article]
- 33.4%
Discovery of the Macrocycle (9E)-15-(2-(Pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a Potent Inhibitor of Janus Kinase 2/Fms-LikeTyrosine Kinase-3 (JAK2/FLT3) for the Treatment of Rheumatoid Arthritis
[Article]
- 33.4%
Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma
[Article]
- 32.8%
Discovery of 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (Nelotanserin) and Related 5-Hydroxytryptamine2A Inverse Agonists for the Treatment of Insomnia
[Article]
|
#RealTimeChem:
Announcements:
|